Loading asset research
Mustang Bio Inc. Common Stock
MBIONasdaq · USD · StocksQuote as of · Exchange session not verified$0.507
-2.50%
Today
MBIO
Loading 1D prices…
Market cap
$3.8M
Volume
25.9K
52w high
$1.8552w low
$0.507Company profile
Mustang Bio Inc. Common Stock
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children's hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Waltham, MA, United States
Employees
4
Fiscal year end
1231
CIK
1680048
Session & valuation
Open$0.532
Previous close$0.52
Day high$0.55
Day low$0.507
30-day avg. volume24.3K
Outstanding shares25M
Diluted EPS-$0.39
Latest annual period
P/E (trailing)-1.30
P/E (forward)-1.45
Price / book0.51
Beta2.05
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| TCRTAlaunos Therapeutics Inc. Common Stock | $3.8M | $5K | -83520.00% | -$2.20 | -3.21% | Unrated |
| CVKDCadrenal Therapeutics Inc. Common Stock | $3.9M | $0.00 | — | -$6.64 | -7.63% | Buy |
| RDHLRedhill Biopharma Ltd. American Depositary Shares | $3.9M | $286K | -150.00% | $0.00 | -1.23% | Unrated |
| REVBRevelation Biosciences Inc. Common Stock | $4M | $0.00 | — | -$23.95 | -0.70% | Buy |
| SILOSilo Pharma Inc. Common Stock | $3.7M | $72.1K | -5863.50% | -$0.50 | -0.19% | Unrated |